After the AI Boom, Exosomes Emerge as the New Investment Darling – Sparking Cross-Border Collaboration Opportunities – TVBS News

TEC Partners with Japan’s Toyota Holdings to Establish a Wholly Owned New Company, Expanding Its Global Regenerative Medicine Presence – CTV News

Global Exosome Boom: Taiwan–Japan Alliance Ushers In a New Era of Regenerative Medicine – ETtoday News

Taiwan’s Exosome Industry Partners with Japan to Advance Regenerative Medicine on the Global Stage – NextTV News

Taiwan and Japan Join Forces to Seize the Exosome Market – Innovative Breakthroughs in Regenerative Medicine Collaboration (TTV News)

Leading a new era in Taiwan’s biotechnology — Taiwan Exosome Company pays a courtesy visit to the Chairman of the Taiwan–Japan Relations Association.

Cultural Exchange and Strategic Partnership — Toyota Executives Visit the Head Office of Bank of Taiwan to Experience a Century of Financial Heritage and Elegance.

A new chapter in Taiwan–Japan relations is unfolding as the fifth-generation heir of the Toyota Motor family visits Taiwan. The Presidential Office emphasized that this historic visit underscores the growing momentum of bilateral ties and expressed hopes

Taiwanese Exosome Companies Partner with Japan’s Toyota Holdings to Expand Internationally, Targeting Global Regenerative Medicine Market

Biotech Blue Ocean: Taiwan and Japan Join Forces to Tap Exosome Opportunities.

Taiwan and Japan Join Forces to Enter the Exosome Market, Opening a New Chapter in Regenerative Medicine Collaboration

TEC and Toyota Holdings Form Joint Venture to Capture the Global Regenerative Medicine Market

Industry Growth Spurs Legislator Chiu Chih-Wei to Propose an 'Exosome Shield,' Urges Regulatory Easing

Targeting the Global Regenerative Medicine Market: Taiwanese Exosome Company Partners with Japan's Toyota Holdings to Promote Industry Upgrading

Taiwanese Exosome Company Partners with Toyota Holdings to Promote Exosomes; Legislator Calls for the Creation of an 'Exosome Shield

Exosome technology targets neurological health — Taiwanese startup builds an integrated academia-industry-clinical platform.

Miniature Couriers Between Cells! Taiwan Biotech Startup Targets Urological Applications to Pioneer Regenerative Medicine

Taiwan Exosome Company has established the first domestic clinical-grade universal (non-matching and non-genetically modified) NK cell platform, possessing the key capability to enter clinical trials. This became the decisive factor for Toyota Holdings Co

Exosome Technology on the Rise — Taiwan Exosome’s Strategic Blueprint for Global Market Expansion

To enhance the overall operational efficiency of the company, the Board of Directors of Medigen Biotech Corp has resolved to form a strategic alliance with Taiwan Exosome Company.

Natural is the best！National-level Biotechnology Center dedicated to research and development「Taiwanese endemic plant-Chenopodium formosanum」

New Breakthrough in Regenerative Medicine！Dr. Du Yuan-Kun's Research:Exosomes Outperform Stem Cells

Research in regenerative medicine is a highly discussed topic in today's medical field. The research team led by Dr. Du Yuan-Kun, a domestic authority in neurological treatment from E-Da Hospital, has found that "exosomes" can effectively repair nerve injuries. This represents an important breakthrough in neuroregenerative medicine, and the results have been published in an international journal.